Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis.

Chen J, Zhang D, Zhang W, Tang Y, Yan W, Guo L, Shen B.

J Transl Med. 2013 Jul 10;11:169. doi: 10.1186/1479-5876-11-169.

2.

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.

He H, Wang L, Zhou W, Zhang Z, Wang L, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X, Ge J.

PLoS One. 2015 May 4;10(5):e0125672. doi: 10.1371/journal.pone.0125672. eCollection 2015.

3.

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.

BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.

4.

Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.

Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y, Zhao X, Liang C, Wang Y, Sun L, Shi M, Xu X, Shen F, Chen M, Han Z, Peng Z, Zhai Q, Chen J, Zhang Z, Yang R, Ye J, Guan Z, Yang H, Gui Y, Wang J, Cai Z, Zhang X.

PLoS One. 2010 Dec 30;5(12):e15224. doi: 10.1371/journal.pone.0015224.

5.

MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P.

Cancer Biol Ther. 2014 Mar 1;15(3):329-41. doi: 10.4161/cbt.27314. Epub 2013 Dec 18.

6.

Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.

Kowalik CG, Palmer DA, Sullivan TB, Teebagy PA, Dugan JM, Libertino JA, Burks EJ, Canes D, Rieger-Christ KM.

BJU Int. 2017 Sep;120(3):428-440. doi: 10.1111/bju.13886. Epub 2017 May 18.

PMID:
28432832
7.

Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.

Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, van Poppel H.

PLoS One. 2012;7(6):e38298. doi: 10.1371/journal.pone.0038298. Epub 2012 Jun 20.

8.

Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.

Zhang W, Zang J, Jing X, Sun Z, Yan W, Yang D, Shen B, Guo F.

J Transl Med. 2014 Mar 11;12:66. doi: 10.1186/1479-5876-12-66.

9.

Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma.

Butz H, Szabó PM, Nofech-Mozes R, Rotondo F, Kovacs K, Mirham L, Girgis H, Boles D, Patocs A, Yousef GM.

Clin Chem. 2014 Oct;60(10):1314-26. doi: 10.1373/clinchem.2014.225854. Epub 2014 Aug 19.

10.

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.

PMID:
24242678
11.

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.

Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, Ganesan S, Levine AJ, Rathmell WK, Bhanot GV.

BMC Syst Biol. 2010 Apr 27;4:51. doi: 10.1186/1752-0509-4-51.

12.

A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.

Ge YZ, Wu R, Xin H, Zhu M, Lu TZ, Liu H, Xu Z, Yu P, Zhao YC, Li MH, Hu ZK, Zhao Y, Zhong B, Xu X, Zhou LH, Xu LW, Wu JP, Li WC, Zhu JG, Jia RP.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1291-9. doi: 10.1007/s00432-015-1927-0. Epub 2015 Jan 30.

PMID:
25633718
13.

Abnormal gene expression profile reveals the common key signatures associated with clear cell renal cell carcinoma: a meta-analysis.

Zhang HJ, Sun ZQ, Qian WQ, Sheng L.

Genet Mol Res. 2015 Mar 27;14(1):2216-24. doi: 10.4238/2015.March.27.7.

14.

Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Osunkoya AO, Yin-Goen Q, Phan JH, Moffitt RA, Stokes TH, Wang MD, Young AN.

Hum Pathol. 2009 Dec;40(12):1671-8. doi: 10.1016/j.humpath.2009.05.006. Epub 2009 Aug 19.

15.

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.

Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM.

Clin Biochem. 2010 Jan;43(1-2):150-8. doi: 10.1016/j.clinbiochem.2009.07.020. Epub 2009 Jul 29.

PMID:
19646430
16.

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Cheville JC, Parker AS.

BMC Urol. 2014 Jan 31;14:14. doi: 10.1186/1471-2490-14-14.

17.

Identification of a microRNA panel for clear-cell kidney cancer.

Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS.

Urology. 2010 Apr;75(4):835-41. doi: 10.1016/j.urology.2009.10.033. Epub 2009 Dec 29.

PMID:
20035975
18.

Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer.

Tang Y, Yan W, Chen J, Luo C, Kaipia A, Shen B.

BMC Syst Biol. 2013 Oct 16;7 Suppl 3:S6. doi: 10.1186/1752-0509-7-S3-S6.

19.

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.

Lawrie CH, Larrea E, Larrinaga G, Goicoechea I, Arestin M, Fernandez-Mercado M, Hes O, Cáceres F, Manterola L, López JI.

J Pathol. 2014 Jan;232(1):32-42. doi: 10.1002/path.4296.

PMID:
24155122
20.

Supplemental Content

Support Center